| Live birth rate | Multiple pregnancy rate | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Studies no. | SET total | DET total | I2 | OR (95%CI) | P value | Studies no. | SET total | DET total | I2 | OR (95%CI) | P value | |
Overall | 62 | 85,988 | 247,116 | 91% | 0.78 (0.71-0.85) | < 0.001 | 45 | 17,979 | 49,645 | 2% | 0.05 (0.04-0.06) | < 0.001 |
Subgroup analyses | ||||||||||||
Maternal age (years) | Â | Â | Â | Â | Â | 0.504* | Â | Â | Â | Â | Â | 0.035* |
   < 35a | 12 | 20,637 | 27,263 | 85% | 0.71 (0.61-0.84) | < 0.001 | 11 | 5061 | 12,322 | 0% | 0.03 (0.03-0.05) | < 0.001 |
  35-40 | 6 | 11,009 | 20,285 | 69% | 0.80 (0.69-0.94) | 0.005 | 5 | 3767 | 15,100 | 0% | 0.04 (0.03-0.06) | < 0.001 |
   ≥ 40 | 4 | 2584 | 3395 | 69% | 0.87 (0.54-1.40) | 0.565 | 3 | 347 | 528 | 0% | 0.34 (0.06-2.03) | 0.236 |
Quality |  |  |  |  |  | – |  |  |  |  |  | – |
  G/GG | 7 | 7293 | 24,514 | 82% | 0.63 (0.52-0.77) | < 0.001 | 10 | 4698 | 3665 | 57% | 0.06 (0.03-0.10) | < 0.001 |
  G/GP | 8 | 7601 | 3308 | 81% | 0.99 (0.77-1.27) | 0.915 | 9 | 4648 | 1470 | 66% | 0.12 (0.06-0.26) | < 0.001 |
  P/PP | 3 | 786 | 681 | 0% | 0.57 (0.45-0.71) | < 0.001 | 6 | 381 | 429 | 54% | 0.23 (0.04-1.49) | 0.123 |
Embryo stage | Â | Â | Â | Â | Â | 0.116* | Â | Â | Â | Â | Â | 0.28* |
  Cleavage | 32 | 40,348 | 140,827 | 96% | 0.67 (0.55-0.82) | < 0.001 | 17 | 5681 | 32,187 | 0% | 0.06 (0.04-0.08) | < 0.001 |
  Blastocyst | 25 | 39,455 | 93,424 | 88% | 0.81 (0.71-0.92) | 0.001 | 22 | 9308 | 14,928 | 25% | 0.05 (0.04-0.06) | < 0.001 |
Cycle | Â | Â | Â | Â | Â | 0.608* | Â | Â | Â | Â | Â | 0.712* |
  Fresh | 53 | 77,288 | 217,979 | 91% | 0.80 (0.72-0.88) | < 0.001 | 36 | 14,391 | 45,104 | 0% | 0.05 (0.05-0.07) | < 0.001 |
  Frozen | 10 | 8541 | 28,928 | 89% | 0.74 (0.59-0.94) | 0.013 | 7 | 3057 | 3885 | 48% | 0.05 (0.03-0.09) | < 0.001 |
Design |  |  |  |  |  | < 0.001* |  |  |  |  |  | 0.73* |
  RCT | 13 | 1044 | 1050 | 0% | 0.53 (0.44-0.63) | < 0.001 | 5 | 222 | 234 | 0% | 0.06 (0.02-0.21) | < 0.001 |
 Observational study | 49 | 84,944 | 246,066 | 93% | 0.82 (0.75-0.90) | < 0.001 | 40 | 17,757 | 49,411 | 11% | 0.05 (0.04-0.06) | < 0.001 |
Sensitivity analyses | ||||||||||||
Adjusted | 12 | 6921 | 28,828 | 41% | 0.77 (0.68-0.87) | < 0.001 | 4 | 797 | 1847 | 0% | 0.06 (0.02-0.16) | < 0.001 |
First cycle | 21 | 76,470 | 235,620 | 96% | 0.70 (0.61-0.81) | < 0.001 | 10 | 11,000 | 41,814 | 54% | 0.05 (0.03-0.07) | < 0.001 |
eSET | 35 | 31,189 | 29,418 | 70% | 0.80 (0.72-0.89) | < 0.001 | 27 | 4245 | 5522 | 0% | 0.05 (0.03-0.07) | < 0.001 |